Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis

BACKGROUND: Eosinophilic granulomatosis with polyangiitis (EGPA) is a disease that is associated with severe uncontrolled eosinophilic asthma. Eosinophils play an important pathogenic role in the development of both diseases. Benralizumab is an antieosinophilic monoclonal antibody that binds to the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Pulm Med
Päätekijät: Martínez-Rivera, Carlos, Garcia-Olivé, Ignasi, Urrutia-Royo, Blanca, Basagaña-Torrento, Maria, Rosell, Antoni, Abad, Jorge
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7819231/
https://ncbi.nlm.nih.gov/pubmed/33478439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-021-01397-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia